tris(2,2'-bipyridine)ruthenium(II) has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hai, Z; Li, J; Liang, G; Xiao, H; Yi, X | 1 |
| Jin, B; Li, X; Li, Y; Song, C; Sun, Y; Tao, L; Yang, K; Zhang, Z | 1 |
2 other study(ies) available for tris(2,2'-bipyridine)ruthenium(II) and Liver Neoplasms
| Article | Year |
|---|---|
Intracellular self-assembly of Ru(bpy)
Topics: Animals; Hep G2 Cells; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Mice; Mice, Nude; Molecular Probes; Nanoparticles; Optical Imaging; Organometallic Compounds; Particle Size; Surface Properties | 2018 |
A fluorescent and chemiluminescent difunctional mesoporous silica nanoparticle as a label for the ultrasensitive detection of cancer cells.
Topics: Cell Line, Tumor; Humans; Liver Neoplasms; Luminescent Agents; Luminescent Measurements; Microscopy, Fluorescence; Nanoparticles; Organometallic Compounds; Oxidation-Reduction; Porosity; Rhodamines; Silicon Dioxide | 2013 |